Literature DB >> 35395026

The new normal: Covid-19 risk perceptions and support for continuing restrictions past vaccinations.

Maja Graso1.   

Abstract

I test the possibility that over-estimating negative consequences of COVID-19 (e.g., hospitalizations, deaths, and threats to children) will be associated with stronger support the 'new normal' (i.e., continuation of restrictions for an undefined period starting with wide-spread access to vaccines and completed vaccinations of vulnerable people). The new normal was assessed by endorsing practices such as vaccine passports, travel restrictions, mandatory masking, continuing contact tracing, and pursuing elimination. Results are based on five samples (N = 1,233 from April 2021 and N = 264 from January 2022) and suggest that people over-estimate COVID-19 risks to children and healthy people, as evidenced by median estimates that 5% of all global deaths were children, 29% were generally healthy people under 65, and that a healthy person under the age of 65 has 5% chance of dying from COVID-19. Over-estimates observed in this study align with those based on representative samples, and they were consistently related to stronger support for the new normal. This relationship emerged when participants estimated risks with percentages (core indicators) and indicated the extent to which risk-based statements are true/supported with evidence or false/unsupported (alternative indicators). People were notably more likely to support continuing restrictions if they believed that COVID-19 risk and risk mitigation tactics are true, even when they are not (e.g., children need to be prioritized for boosters). These relationships persisted when considering competing explanations (political ideology, statistics literacy, belief in conspiracy theories). I trace these effects to well-meaning efforts to prevent under-estimation. Public policy and people's perceptions of risks are intertwined, where even inaccurate judgments may influence decisions. Failure to combat all misinformation with equal rigor may jeopardize the restoration of the social and economic life essential for building adaptive post-pandemic societies.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35395026      PMCID: PMC8993013          DOI: 10.1371/journal.pone.0266602

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  81 in total

1.  Assessing the risks of 'infodemics' in response to COVID-19 epidemics.

Authors:  Riccardo Gallotti; Francesco Valle; Nicola Castaldo; Pierluigi Sacco; Manlio De Domenico
Journal:  Nat Hum Behav       Date:  2020-10-29

2.  Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.

Authors:  Anna Wald
Journal:  JAMA       Date:  2022-01-25       Impact factor: 56.272

3.  Face masks: what the data say.

Authors:  Lynne Peeples
Journal:  Nature       Date:  2020-10       Impact factor: 49.962

4.  Will Student Contracts Keep Campuses Safe From COVID-19? A Behavioral Science Perspective.

Authors:  Alyssa M Lederer; Jeni A Stolow
Journal:  Public Health Rep       Date:  2021-02-22       Impact factor: 2.792

5.  Second versus first wave of COVID-19 deaths: shifts in age distribution and in nursing home fatalities.

Authors:  John P A Ioannidis; Cathrine Axfors; Despina G Contopoulos-Ioannidis
Journal:  Environ Res       Date:  2021-02-10       Impact factor: 6.498

6.  SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg.

Authors:  Paul Wilmes; Jacques Zimmer; Jasmin Schulz; Frank Glod; Lisa Veiber; Laurent Mombaerts; Bruno Rodrigues; Atte Aalto; Jessica Pastore; Chantal J Snoeck; Markus Ollert; Guy Fagherazzi; Joël Mossong; Jorge Goncalves; Alexander Skupin; Ulf Nehrbass
Journal:  Lancet Reg Health Eur       Date:  2021-02-27

7.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.

Authors:  Sam Abbott; Rosanna C Barnard; Christopher I Jarvis; Adam J Kucharski; James D Munday; Carl A B Pearson; Timothy W Russell; Damien C Tully; Alex D Washburne; Tom Wenseleers; Nicholas G Davies; Amy Gimma; William Waites; Kerry L M Wong; Kevin van Zandvoort; Justin D Silverman; Karla Diaz-Ordaz; Ruth Keogh; Rosalind M Eggo; Sebastian Funk; Mark Jit; Katherine E Atkins; W John Edmunds
Journal:  Science       Date:  2021-03-03       Impact factor: 63.714

8.  Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review.

Authors:  João Vitor Vieira de Siqueira; Lucas Garrido Almeida; Bruno Otávio Zica; Ingred Batista Brum; Alberto Barceló; Arise Garcia de Siqueira Galil
Journal:  Obes Res Clin Pract       Date:  2020-07-23       Impact factor: 2.288

9.  Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters.

Authors:  John P A Ioannidis; Cathrine Axfors; Despina G Contopoulos-Ioannidis
Journal:  Environ Res       Date:  2020-07-01       Impact factor: 6.498

10.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D A M P J Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-10       Impact factor: 3.944

View more
  1 in total

Review 1.  Aggressive measures, rising inequalities, and mass formation during the COVID-19 crisis: An overview and proposed way forward.

Authors:  Michaéla C Schippers; John P A Ioannidis; Ari R Joffe
Journal:  Front Public Health       Date:  2022-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.